在线观看人与动牲交视频_夜夜高潮次次欢爽AV女_奇米在线视频观看_欧美精品七区_色悠久久综合网_少妇潮喷无码白浆水视频

 康弘藥業 Kanghong Pharmaceuticals 
成都康弘藥業集團股份有限公司（以下簡稱康弘藥業）是一家致力于中成藥、化學藥及生物制品的研發、生產、銷售及售后服務的現代化醫藥企業集團，總部位于四川成都。集團成員有：
成都康弘制藥有限公司
四川濟生堂藥業有限公司
成都弘達藥業有限公司
成都康弘生物科技有限公司
四川康弘醫藥貿易有限公司
成都康弘醫藥貿易有限公司
四川康弘中藥材種植有限公司
四川康弘合成制藥有限公司
四川濟生堂中藥飲片有限公司
康弘賽金（成都）藥業有限公司（中外合資）
現有員工3000余人，擁有中成藥、化學藥和生物制品生產基地，銷售網絡遍布全國31個省、市、自治區。
2008年，在中國化學制藥工業協會組織的首批全國制藥企業信用評價中，集團成為全國僅有的七家獲得"AAA級企業信用等級"的制藥企業之一，集團三個生產基地也在08年同時榮獲"四川省質量信用AAA級企業"、"四川省質量管理先進企業"榮譽稱號；2009年，集團榮獲中國醫藥30年風云會改革開放三十年"創新獎"。2009年，集團商標""被認定為"中國馳名商標"。

自成立以來，集團獲得了各級政府的關心指導及社會各界的廣泛關注：中共中央政治局常委周永康，全國人大副委員長烏云其木格，前國務院副總理李嵐清等國家領導人及省市各級領導多次蒞臨視察指導；美國貿易政策及談判顧問委員會等各國政、商、學界代表嘉賓多次來集團考察洽談。


Chengdu Kanghong Pharmaceuticals Group Co., Ltd. is a modern medicinal consortium of nine subsidiaries and a joint-venture company, all located in Chengdu, China. There are over 3000 employees. Kanghong’s core business is to develop, produce and market Traditional Chinese Medicine, small molecule and biologic drugs.

Since the establishment of the Group, the goal of the enterprise, from which the name of the company is derived, has been ‘to contribute to the prosperity of society and the health of the people’. ‘Prosperity’ means to create greater value for the country and people. ‘Health’ means to provide the best medical service and products possible. The consortium companies and staff concentrate all resources to engage in the development, preparation and distribution of medicines in cardiovascular, central nervous system, digestion, respiration, endocrinology and oncology. The Group and its staff strive to be one of the most outstanding pharmaceutical companies in China.

Since the establishment of the Group, it has received wide-spread support from various levels of government, clients and consumers from all walks of life. The Group has received the “Important Enterprise with Advantages” award at provincial and city levels for 5 successive years, and was presented the “Industrial Enterprise with Outstanding Contribution” award in Sichuan province in 2006.